Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUSD428650 S
Publication typeGrant
Application numberUS 29/101,529
Publication dateJul 25, 2000
Filing dateMar 5, 1999
Priority dateSep 8, 1998
Publication number101529, 29101529, US D428650 S, US D428650S, US-S-D428650, USD428650 S, USD428650S
InventorsEmily L. Bellhouse, Graeme L. J. Paterson
Original AssigneePowderject Research Limited
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
US D428650 S
Abstract  available in
Previous page
Next page
  1. The ornamental design for an injector, as shown and described.

FIG. 1 is a perspective view of an injector viewed from the upper front left side showing our new design;

FIG. 2 is a perspective view of the injector viewed from the lower front left side;

FIG. 3 is an elevational right side view thereof;

FIG. 4 is an elevational front view thereof;

FIG. 5 is an elevational left side view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof; and,

FIG. 8 is an elevational rear view thereof.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6626871Oct 10, 2000Sep 30, 2003Felton International, Inc.Method and apparatus for removing cap from medical device
US6802826Oct 10, 2000Oct 12, 2004Felton International, Inc.Universal anti-infectious protector for needleless injectors
US7255865Jan 17, 2002Aug 14, 2007Allergan, Inc.Methods of administering botulinum toxin
US7479281Oct 4, 2006Jan 20, 2009Allergan, Inc.Botulinum toxin for treating postherpetic neuralgia
US7887506Nov 21, 2000Feb 15, 2011Pulse Needlefree Systems, Inc.Safety mechanism to prevent accidental patient injection and methods of same
US8025889Dec 19, 2008Sep 27, 2011Allergan, Inc.Botulinum toxin administration to treat various conditions
US8420105Aug 18, 2011Apr 16, 2013Allergan, Inc.Botulinum toxin administration to treat various conditions
U.S. ClassificationD24/112, D24/113, D24/114